Jiangsu Hengrui Medicine’s $87.75 Million License Agreement with CrystalGenomics

Sidley Austin LLP advised Jiangsu Hengrui Medicine Co., Ltd. in entering into a license agreement with CrystalGenomics, Inc. Crystal Genomics (KOSDAQ: 083790), a South Korea-based biopharmaceutical…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here